Tue. 5 Mar 2024, 6:55am ET
Benzinga
Earnings, News
Sophia Genetics (NASDAQ:SOPH) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.27) by 37.04 percent. This is a 117.65 percent decrease over losses of $(0.17) per share from the same period last year. The company reported quarterly sales of $17.05 million which missed the analyst consensus estimate of $17.33 million by 1.63 percent. This is a 27.38 percent increase over sales of $13.38 million the same period last year.